# Taiho Ventures

Taiho Ventures is a Venture Capital based in Menlo Park, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Menlo Park, United States
- **Region:** Middle East
- **Address:** Menlo Park, CA, United States
- **Founded:** 2017
- **Assets under management:** $100M - $500M (Altss estimate)
- **Website:** www.taihoventures.com
- **LinkedIn:** https://www.linkedin.com/company/taiho

## Regulatory record

- **Reports private funds:** No

## About

Taiho Ventures, LLC is the corporate venture arm of Taiho Pharmaceutical Co., Ltd., a Japanese specialty pharmaceutical company focusing on oncology, allergy and immunology, and urology. With $400M under management, it actively invests in early stage private companies strategically relevant to Taiho Pharmaceutical. It considers company creation, spinouts and the option-type of investments as well as pure equity investments. Its mission is to create significant values from investing in the global biotech venture community and provide innovative science for Taiho Pharmaceutical Co., Ltd.

## Sectors

- Digital Health
- Healthcare Services
- AI/ML
- Enterprise Software

## Offices

- Abu Dhabi, United Arab Emirates
- Princeton, NJ, United States
- Chicago, IL, United States

## People

- Sakae Asanuma — Founder & Managing Partner

## Questions

### Who leads investment decisions at Taiho Ventures?

Founder and Managing Partner Sakae Asanuma chairs the investment committee, drawing on his tenure as President of Astellas Pharma US. Day-to-day deal sourcing and diligence is conducted by a core team spread across the Menlo Park, Princeton, and Abu Dhabi offices, blending pharmaceutical operational experience with institutional venture backgrounds.

### How is Taiho Ventures related to Taiho Pharmaceutical?

The firm operates independently but maintains a strategic relationship with Taiho Pharmaceutical, a Japanese oncology-focused pharma company that is one of its capital partners. Taiho Ventures is not a captive corporate venture arm; it manages capital from multiple sources, including family offices and sovereign-linked entities, allowing it to pursue investments beyond the parent pharma's immediate pipeline priorities.

### Does Taiho participate in fund commitments or only direct deals?

Taiho Ventures is structured for direct early-stage equity investments and spin-off financings. There is no public record of the firm allocating to third-party venture funds as a limited partner, reinforcing its posture as a direct, thesis-driven investor rather than a fund-of-funds allocator.

## Related profiles

- [Taihill Venture](https://altss.com/profile/taihill-venture)
- [Taihua Venture Capital](https://altss.com/profile/taihua-venture-capital)

---

Last updated: 2026-08-11T15:08:18.003Z

Canonical page: https://altss.com/profile/taiho-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology